Robert M. Gervis, Director at ASPEN AEROGELS INC (ASPN), bought 7,100 shares at $3.95 ($28K) on 2017-03-21, disclosed to the SEC on 2017-03-22.
Scheduled purchase ($28k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.99 | 1,400 | $6K | 19.8% |
| 2 | $3.99 | 1,500 | $6K | 21.2% |
| 3 | $3.95 | 2,100 | $8K | 29.4% |
| 4 | $3.96 | 2,100 | $8K | 29.5% |
| Total | $3.97 avg | 7,100 | $28K | 100% |
| Filing → |
| ASPN | BUY | 2017-05-08 | $3K | — | Filing → |
| ASPN | BUY | 2017-05-04 | $2K | — | Filing → |
| ASPN | BUY | 2017-05-02 | $1K | — | Filing → |